Next 10 |
2025-02-13 05:10:59 ET Summary Acadia Pharmaceuticals has shown significant financial improvement, reporting a profit of $82.7m in 2024, compared to a loss of $(107m) in 2023. The company's revenue growth is driven by NUPLAZID and DAYBUE, with 2024 revenue projections of $600m-$61...
Company to host conference call and webcast on Wednesday, February 26, 2025, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2024 financial results on Wednesday, February 26, 2025, after the close of...
2025-01-29 08:05:23 ET Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally sound stocks like Viatris (VTRS), Bausch + Lomb Corp. (BLCO), ...
2025-01-14 12:41:27 ET More on Acadia Pharma Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET Acadia Pharmaceuticals: Proving The Naysayers Wrong ACADIA Pharmaceuticals Inc. (ACAD) Q3 2024 Earnings Conference Call Transcript Acadia clo...
2024-12-31 04:53:33 ET On the final trading day of 2024, US stock futures were mainly lower following a third straight drop in Wall Street's S&P 500 and Nasdaq.... Read the full article on Seeking Alpha For further details see: Biggest stock movers Tuesday: VSTM, ACAD
2024-12-31 02:35:38 ET More on Acadia Pharma Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET Acadia Pharmaceuticals: Proving The Naysayers Wrong Acadia closes on $150M FDA voucher sale Acadia signs licensing deal for essential tremor ...
Acadia Pharmaceuticals Set to Join S&P SmallCap 600 Acadia Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX)...
2024-12-24 10:13:46 ET The specialty pharma sector is leading the charge in developing life-changing solutions for rare and chronic conditions. Amid this backdrop, investors might consider adding three fundamentally solid specialty pharma stocks, namely, Ipsen S.A. (IPSEY), ACADIA Pharmac...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive Officer will represent the Company in a session scheduled on Tuesday, January 14, 2025, at 9:00 a.m....
2024-12-12 13:08:14 ET More on Acadia Pharma Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET Acadia Pharmaceuticals: Proving The Naysayers Wrong ACADIA Pharmaceuticals Inc. (ACAD) Q3 2024 Earnings Conference Call Transcript Acadia sig...
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
Company to host conference call and webcast on Wednesday, February 26, 2025, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2024 financial results on Wednesday, February 26, 2025, after the close of...
2025-01-29 08:05:23 ET Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally sound stocks like Viatris (VTRS), Bausch + Lomb Corp. (BLCO), ...
Acadia Pharmaceuticals Set to Join S&P SmallCap 600 Acadia Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX)...